SCHEMBL6201070

SCHEMBL6201070

CCCOC(=O)c1c(NC(=O)CN2CCCCC2)sc2c1CCCC2

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.70
SMN1; SMN2 Q16637 4/20 0.70
TSHR P16473 6/20 0.70
HSD17B10 Q99714 3/20 0.70
ALOX15 P16050 2/20 0.70
MAPK1 P28482 1/20 0.70
TLR2 O60603 2/20 0.68
CNR2 P34972 5/20 0.67
HPGD P15428 4/20 0.65
GAA P10253 2/20 0.65
MAPT P10636 4/20 0.64
NPSR1 Q6W5P4 3/20 0.64
TP53 P04637 2/20 0.64
MEN1 O00255 1/20 0.64
KMT2A Q03164 1/20 0.64
KDM4E B2RXH2 3/20 0.60
CNR1 P21554 1/20 0.58
LMNA P02545 1/20 0.57
HTT P42858 1/20 0.57
ESR2 Q92731 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203156 0.91 ALDH1A1 (0.82) ALDH1A1SMN1; SMN2TSHRHSD17B10ALOX15
SCHEMBL6200055 0.91 ALDH1A1 (0.82) ALDH1A1SMN1; SMN2TSHRHSD17B10ALOX15
SCHEMBL6205044 0.90 ALDH1A1 (0.84) ALDH1A1SMN1; SMN2TSHRHSD17B10ALOX15
SCHEMBL6202090 0.89 ALDH1A1 (0.79) ALDH1A1SMN1; SMN2TSHRHSD17B10ALOX15
SCHEMBL6203815 0.89 ALDH1A1 (0.79) ALDH1A1SMN1; SMN2TSHRHSD17B10ALOX15
SCHEMBL6203540 0.88 ALDH1A1 (0.80) ALDH1A1SMN1; SMN2TSHRHSD17B10ALOX15
SCHEMBL6203821 0.88 ALDH1A1 (0.84) ALDH1A1SMN1; SMN2TSHRHSD17B10ALOX15
SCHEMBL6263808 0.88 CNR2 (0.73) ALDH1A1SMN1; SMN2TSHRHSD17B10ALOX15
SCHEMBL6204167 0.84 LMNA (0.70) ALDH1A1SMN1; SMN2TSHRHSD17B10ALOX15
SCHEMBL3980443 0.82 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2TSHRHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509514-A1 ANTHELMINTIC AND INSECTICIDAL THIOPHENE DERIVATIVES PHARMACIA & UPJOHN COMPANY (US) 2005-03-02 EP claimed
US-20040014740-A1 Novel anthelmintic and insecticidal compositions PHARMACIA & UPJOHN COMPANY 2004-01-22 US claimed
WO-2003101979-A1 ANTHELMINTIC AND INSECTICIDAL THIOPHENE DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2003-12-11 WO claimed
EP-1509514-A1 ANTHELMINTIC AND INSECTICIDAL THIOPHENE DERIVATIVES PHARMACIA & UPJOHN COMPANY (US) 2005-03-02 EP disclosed
US-20040014740-A1 Novel anthelmintic and insecticidal compositions PHARMACIA & UPJOHN COMPANY 2004-01-22 US disclosed
WO-2003101979-A1 ANTHELMINTIC AND INSECTICIDAL THIOPHENE DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014740-A1 Novel anthelmintic and insecticidal compositions ACHE, BCHE, AADAC ALDH1A1 2781/4885SMN1; SMN2 3997/4885TSHR 4483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.